Cell Dissociation

Cell Dissociation Market Outlook

The global cell dissociation market is poised for substantial growth, projected to reach approximately USD 2.5 billion by 2035, expanding at a remarkable compound annual growth rate (CAGR) of around 8.5% during the forecast period of 2025-2035. Factors driving this growth include an increase in research activities in the fields of cell biology and regenerative medicine, along with rising prevalence of cancer and other chronic diseases that necessitate advanced research methodologies. Furthermore, the growing demand for novel therapeutics and personalized medicine is significantly contributing to the expansion of this market. Technological advancements in cell dissociation techniques and the rising number of collaborations between research institutions and biotech companies are also propelling market growth. Additionally, the surge in funding for life sciences research is expected to further enhance the market landscape over the coming years.

Growth Factor of the Market

The cell dissociation market is witnessing a surge in growth, driven primarily by technological advancements and increased investments in biomedical research. The rising prevalence of cancer and chronic diseases necessitates the development of new therapeutic solutions, thereby increasing demand for effective cell dissociation methods. Moreover, the expansion of stem cell research and its applications in regenerative medicine are creating lucrative opportunities for key players in this sector. The growing trend towards personalized medicine is further influencing market dynamics, as researchers require precise cell dissociation techniques for the development of patient-specific therapies. Additionally, collaborations between academic institutions and biotech firms are fueling innovation and improving product offerings, which in turn contributes to market expansion. The regulatory environment is also becoming more favorable, allowing for accelerated approval processes for innovative cell dissociation products.

Key Highlights of the Market

• The global cell dissociation market is projected to reach USD 2.5 billion by 2035.
• Significant growth is anticipated due to advancements in cell dissociation technologies.
• Rising prevalence of chronic diseases and cancer is driving research demand.
• Increased governmental and private funding for biomedical research fuels market growth.
• Collaborations between academia and industry strengthen innovation in product development.

By Product Type

Enzymatic Dissociation Reagents:

Enzymatic dissociation reagents play a vital role in the cell dissociation market, as they are essential for the enzymatic breakdown of extracellular matrices and cell-cell junctions. These reagents are predominantly used in culture applications where gentle dissociation is required, ensuring cell viability and functionality post-dissociation. Common enzymes used include trypsin and collagenase, which are favored for their efficiency in separating adherent cells from their substrate. The demand for enzymatic dissociation reagents is on the rise due to their widespread utilization in various applications, including stem cell research and drug discovery processes. This segment showcases a strong growth trajectory, driven by ongoing research in cell-based therapies and advancements in biopharmaceuticals.

Mechanical Dissociation Reagents:

Mechanical dissociation reagents are crucial for physically separating cells from tissues, utilizing methods such as homogenization and shearing forces. These reagents are particularly important in applications where enzymatic approaches are not suitable or desired, providing a non-chemical alternative for cell dissociation. Mechanical dissociation techniques are favored for their ability to maintain cell integrity and functionality, especially in the preparation of primary cell cultures. As the demand for high-quality cell preparations continues to grow, mechanical dissociation reagents are expected to see increased adoption across various research sectors, contributing to the overall market expansion.

Cell Dissociation Kits:

Cell dissociation kits offer a comprehensive solution for researchers, combining reagents and protocols in a convenient package. These kits simplify the process of cell dissociation, saving valuable time and reducing the risk of inconsistencies that can arise from manual reagent preparation. They are designed for specific cell types and applications, ensuring optimal performance and high yields. The growing trend towards standardized protocols in research laboratories is driving the demand for cell dissociation kits, as they provide reliability and ease of use for researchers. With an increasing number of innovations in kit formulations, this segment is likely to capture a significant share of the market.

Tissue Dissociation Kits:

Tissue dissociation kits are specialized products designed for the efficient dissociation of tissues into single-cell suspensions. These kits use a combination of mechanical and enzymatic methods to achieve optimal results, enabling researchers to obtain viable, high-quality cells from various tissue types. The rising focus on tissue-based research, particularly in areas like cancer immunotherapy and regenerative medicine, is propelling the growth of tissue dissociation kits. Researchers are increasingly utilizing these kits for applications in drug discovery and development, further enhancing their market presence. As precision medicine continues to revolutionize healthcare, the demand for effective tissue dissociation solutions will likely grow significantly.

Others:

The 'Others' segment encompasses various alternative techniques and products not classified under the primary categories of enzymatic and mechanical reagents. This includes novel approaches and emerging technologies such as physical dissociation methods using microfluidics or acoustic waves, which are gaining traction in research settings. As researchers continually seek innovative solutions to improve cell dissociation efficiency and cell viability, this segment is expected to experience growth. The integration of advanced technologies into cell dissociation methods is likely to attract attention and investment, thus contributing positively to the overall market landscape.

By Application

Biomedical Research:

Biomedical research represents one of the most significant applications of cell dissociation, involving a broad spectrum of studies aimed at understanding disease mechanisms and developing therapeutic interventions. Researchers utilize cell dissociation techniques to isolate specific cell types from biological samples for further analysis. The increasing funding for biomedical research projects, coupled with growing interest in understanding complex biological systems, is driving the demand for cell dissociation technologies. Enhanced focus on translational research, which bridges the gap between laboratory findings and clinical applications, is further propelling the need for high-quality dissociated cells in this field.

Stem Cell Research:

Stem cell research is a rapidly growing area within the biomedical field, significantly impacting the cell dissociation market. As stem cells hold immense potential for regenerative medicine and tissue engineering, efficient dissociation methods are crucial for isolating and expanding these cells. Advanced cell dissociation techniques allow researchers to obtain viable stem cells that retain their pluripotency, making them suitable for various applications. The increasing investment in stem cell research, alongside the growing number of clinical trials focusing on stem cell therapies, is expected to enhance the demand for cell dissociation products specifically tailored for stem cell applications.

Drug Discovery:

Drug discovery is a critical phase in pharmaceutical development, and efficient cell dissociation techniques are essential for generating cell-based assays and screening platforms. By obtaining viable, homogeneous cell populations, researchers can evaluate drug responses and mechanisms of action effectively. As the pharmaceutical industry increasingly shifts towards cell-based models for drug testing, the demand for effective cell dissociation methodologies is expected to rise considerably. Furthermore, as personalized medicine gains traction, the need for customized assays using patient-derived cells will further bolster the growth of this market segment.

Cancer Research:

Cancer research is another prominent application driving the cell dissociation market, as it requires the isolation of specific cancer cell types for in-depth study and therapeutic development. The ability to dissociate tumor tissues into single-cell suspensions is crucial for understanding tumor heterogeneity and drug resistance mechanisms. Enhanced focus on immunotherapy and targeted therapies in cancer treatment has led to an increased need for high-quality dissociated cancer cells for research purposes. The growing prevalence of cancer worldwide and the urgent need for novel therapeutic strategies are expected to fuel the demand for cell dissociation technologies tailored specifically for cancer research applications.

Others:

The 'Others' category includes various emerging applications of cell dissociation technologies across diverse fields, such as tissue engineering, diagnostics, and veterinary medicine. As researchers explore the potential of regenerative medicine and tissue engineering, effective cell dissociation methods become essential for creating functional tissue constructs. Additionally, advancements in diagnostic techniques utilizing dissociated cells for biomarker identification are gaining traction. This segment is likely to experience growth as interdisciplinary research expands, and new applications for cell dissociation technologies are discovered.

By Distribution Channel

Biotechnology Companies:

Biotechnology companies are pivotal players in the cell dissociation market, providing innovative products and solutions tailored for researchers and healthcare professionals. These companies invest heavily in research and development to create advanced dissociation reagents and kits that meet the diverse needs of their customers. The increasing number of biotech startups focusing on cell-based therapies and diagnostics is further driving the demand for cell dissociation products. Additionally, collaborations between biotechnology firms and research institutions enhance the availability of cutting-edge technologies and drive market growth.

Research Institutes:

Research institutes play a crucial role in the cell dissociation market, as they are often at the forefront of biomedical research and innovation. These institutions require high-quality cell dissociation products to facilitate their studies across various applications. The collaboration between research institutes and commercial entities fosters the development of new technologies and methods, ultimately benefiting the market. As the global emphasis on research funding continues to rise, research institutes are expected to remain significant consumers of cell dissociation products, ensuring consistent demand in the market.

Hospitals & Diagnostic Laboratories:

Hospitals and diagnostic laboratories are essential distribution channels for cell dissociation products, particularly in clinical settings where accurate cell isolation is necessary for diagnostics and treatment planning. The integration of cell dissociation technologies into routine laboratory practices enhances the efficiency and accuracy of diagnostic procedures. As the demand for personalized medicine and advanced diagnostics grows, hospitals and diagnostic laboratories are expected to increase their utilization of cell dissociation products, contributing to overall market growth.

Pharmaceutical Companies:

Pharmaceutical companies are significant players in the cell dissociation market, utilizing these technologies extensively in drug development and testing processes. The need for rigorous cell testing to evaluate drug efficacy and safety drives the demand for reliable cell dissociation products. As pharmaceutical companies increasingly adopt cell-based assays for drug discovery, the market for cell dissociation products tailored for this sector is expected to expand. Moreover, partnerships between pharmaceutical firms and biotechnology companies may lead to innovative solutions in cell dissociation, further propelling market growth.

Others:

The 'Others' category includes various alternative distribution channels, such as online retailers, academic institutions, and specialty distributors. The rise of e-commerce platforms for laboratory supplies has made cell dissociation products more accessible to researchers and clinicians, facilitating increased adoption across different sectors. As the market continues to evolve, these alternative distribution channels are likely to capture a growing share, driven by the demand for convenient purchasing options and timely access to essential laboratory products.

By Ingredient Type

Trypsin:

Trypsin is one of the most widely used enzymes in cell dissociation, particularly for detaching adherent cells from culture surfaces. It functions by cleaving peptide bonds and is preferred due to its effectiveness in maintaining cell viability during dissociation. The demand for trypsin is significant, given its extensive applications in cell culture and research, including stem cell and cancer research. As researchers seek reliable methods for cell dissociation, the continued use of trypsin is expected to contribute substantially to market growth, particularly in laboratories focusing on cell-based assays and therapeutic development.

Collagenase:

Collagenase is another key enzyme used in cell dissociation, particularly for dissociating tissues rich in collagen, such as connective tissues and tumors. Its ability to selectively degrade the extracellular matrix makes it an essential tool in tissue engineering and regenerative medicine applications. The increasing focus on developing tissue-based therapies and regenerative solutions is driving the demand for collagenase in the market. As researchers continue to explore complex tissue structures, the role of collagenase in facilitating cell dissociation will become even more critical in the upcoming years.

Dispase:

Dispase is a unique enzyme that is highly effective in dissociating epithelial tissues without significantly damaging the cells, making it a preferred choice in cell culture and regenerative medicine applications. Its gentle action is particularly advantageous when isolating specific cell populations for functional studies or therapeutic applications. As the emphasis on maintaining cell integrity during dissociation continues to grow, the demand for dispase is expected to increase. Researchers focusing on epithelial cell biology and tissue regeneration will likely drive further growth in this segment.

Hyaluronidase:

Hyaluronidase is an important enzyme that facilitates cell dissociation by breaking down hyaluronic acid, a key component of the extracellular matrix. Its application is crucial in studies involving various connective tissues, as it enhances cell separation and improves cell yields. The growing interest in understanding diseases related to hyaluronic acid metabolism and its implications in cancer and inflammatory conditions is expected to bolster the demand for hyaluronidase in the market. As researchers continue to investigate the role of hyaluronic acid in cellular processes, the utilization of hyaluronidase will likely increase.

Others:

The 'Others' segment encompasses various alternative ingredients utilized in cell dissociation, including proteases and various formulations designed for specific cell types. As research progresses, novel enzymes and formulations are continually being developed to enhance the efficiency and specificity of cell dissociation methods. The emergence of alternative ingredients that can cater to unique research needs will likely contribute positively to the market, as researchers seek innovative solutions to improve their methodologies. This segment is expected to see growth as the demand for customized dissociation solutions rises.

By Region

The North American region holds a dominant position in the global cell dissociation market, accounting for approximately 40% of the total market share in 2023. This dominance is primarily driven by the presence of advanced research institutions, major biotechnology companies, and extensive funding for biomedical research in the region. The ongoing emphasis on innovative therapies and personalized medicine is further enhancing the demand for high-quality cell dissociation products. Additionally, the region's well-established healthcare infrastructure and regulatory frameworks promote the development and adoption of cutting-edge technologies in cell dissociation, ensuring continued growth in this segment.

In Europe, the cell dissociation market is expected to witness robust growth, with a projected CAGR of 7.5% from 2025 to 2035. The increasing focus on regenerative medicine, coupled with rising research activities in academic and clinical settings, is driving market expansion. The presence of key players and a strong emphasis on collaborative research initiatives contribute to the growth of this market segment. Furthermore, the growing awareness of the importance of cell-based therapies and advancements in biotechnology are likely to continue benefiting the European cell dissociation market, positioning it as a crucial player on the global stage.

Opportunities

The cell dissociation market offers numerous opportunities for growth and innovation, particularly in the realm of personalized medicine and regenerative therapies. As the demand for tailored treatment approaches increases, researchers will require more sophisticated cell dissociation methods to isolate specific cell populations from patient samples. This demand creates an avenue for companies to invest in the development of specialized products and techniques that cater to the unique needs of personalized medicine. Additionally, advancements in technologies such as microfluidics and automated cell dissociation systems present opportunities for enhancing efficiency and precision in laboratory settings, enabling researchers to achieve higher yields and better cell viability.

Furthermore, collaborations between biotechnology firms, research institutions, and academic organizations are expected to foster innovation and speed up the development of new cell dissociation products. These partnerships can lead to the exploration of novel approaches, such as combining mechanical and enzymatic methods for optimal cell recovery. Moreover, as global health challenges evolve, the need for effective cell dissociation technologies in emerging fields such as immuno-oncology, gene therapy, and tissue engineering will continue to expand. By capitalizing on these opportunities, stakeholders in the cell dissociation market can position themselves for sustained growth and success in the evolving landscape of biomedical research.

Threats

Despite the promising growth prospects, the cell dissociation market faces several threats that could hinder its expansion. One significant challenge is the increasing competition from alternative methods and technologies that may offer more efficient or cost-effective solutions for cell dissociation. As researchers seek ways to optimize their workflows, they may gravitate towards newer methods that bypass traditional enzymatic or mechanical dissociation techniques. Additionally, the rapid pace of technological advancement in the biotechnology sector means that companies must consistently innovate and adapt their product offerings to remain relevant in the market. Failure to keep up with advancements could result in decreased market share and profitability.

Moreover, fluctuating regulatory landscapes across different regions can pose challenges for companies operating in the cell dissociation market. Compliance with stringent regulatory requirements is essential for product approval and market access, and any changes in these regulations may impact the supply chain and product development timelines. Furthermore, economic downturns and budget constraints in research funding may limit the purchasing power of research and clinical institutions, potentially affecting the overall demand for cell dissociation products. Addressing these threats will require proactive strategies and a commitment to continuous improvement within the industry.

Competitor Outlook

• Thermo Fisher Scientific
• Merck KGaA
• BD Biosciences
• STEMCELL Technologies
• Sigma-Aldrich (MilliporeSigma)
• Lonza Group
• Corning Incorporated
• Promega Corporation
• Cell Signaling Technology
• Bio-Rad Laboratories
• PerkinElmer
• Takara Bio
• Roche
• Gibco (part of Thermo Fisher Scientific)
• F. Hoffmann-La Roche AG

The competitive landscape of the cell dissociation market is characterized by the presence of numerous established companies and emerging players, each striving for market share through innovation and strategic partnerships. Major companies such as Thermo Fisher Scientific, Merck KGaA, and BD Biosciences dominate the market, leveraging their extensive portfolios of cell dissociation products and reagents. These firms invest heavily in research and development to enhance their product offerings, ensuring they meet the evolving needs of researchers and healthcare professionals. Furthermore, many companies are expanding their global reach through acquisitions and collaborations, allowing them to tap into new markets and strengthen their positions in the cell dissociation sector.

In addition to the established players, several smaller, innovative companies have entered the market, focusing on niche applications and specialized products. These companies often emphasize unique technologies or methodologies that differentiate them from larger competitors. For instance, firms specializing in microfluidic-based cell dissociation systems or alternative enzymatic formulations are increasingly gaining traction among researchers seeking new solutions. This dynamic competitive environment creates a rich landscape for innovation, where companies must continuously adapt to changes in market demands and technological advancements.

To remain competitive, companies in the cell dissociation market are also focusing on strategic collaborations with academic institutions and research organizations. These partnerships often facilitate the development of novel products and methodologies, enabling companies to create solutions that address specific challenges faced by researchers. Additionally, educational initiatives and workshops are becoming increasingly important, as companies seek to enhance awareness of their products and provide training to researchers on optimal usage. Overall, the competitive landscape of the cell dissociation market is vibrant and evolving, with continuous innovation and collaboration driving growth and expansion.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Roche
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Takara Bio
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Lonza Group
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 PerkinElmer
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 BD Biosciences
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Promega Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Bio-Rad Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Corning Incorporated
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 STEMCELL Technologies
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 F. Hoffmann-La Roche AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Thermo Fisher Scientific
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Cell Signaling Technology
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Sigma-Aldrich (MilliporeSigma)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Gibco (part of Thermo Fisher Scientific)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Cell Dissociation Market, By Application
    • 6.1.1 Biomedical Research
    • 6.1.2 Stem Cell Research
    • 6.1.3 Drug Discovery
    • 6.1.4 Cancer Research
    • 6.1.5 Others
  • 6.2 Cell Dissociation Market, By Product Type
    • 6.2.1 Enzymatic Dissociation Reagents
    • 6.2.2 Mechanical Dissociation Reagents
    • 6.2.3 Cell Dissociation Kits
    • 6.2.4 Tissue Dissociation Kits
    • 6.2.5 Others
  • 6.3 Cell Dissociation Market, By Ingredient Type
    • 6.3.1 Trypsin
    • 6.3.2 Collagenase
    • 6.3.3 Dispase
    • 6.3.4 Hyaluronidase
    • 6.3.5 Others
  • 6.4 Cell Dissociation Market, By Distribution Channel
    • 6.4.1 Biotechnology Companies
    • 6.4.2 Research Institutes
    • 6.4.3 Hospitals & Diagnostic Laboratories
    • 6.4.4 Pharmaceutical Companies
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Cell Dissociation Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Cell Dissociation market is categorized based on

By Product Type

• Enzymatic Dissociation Reagents
• Mechanical Dissociation Reagents
• Cell Dissociation Kits
• Tissue Dissociation Kits
• Others

By Application

• Biomedical Research
• Stem Cell Research
• Drug Discovery
• Cancer Research
• Others

By Distribution Channel

• Biotechnology Companies
• Research Institutes
• Hospitals & Diagnostic Laboratories
• Pharmaceutical Companies
• Others

By Ingredient Type

• Trypsin
• Collagenase
• Dispase
• Hyaluronidase
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Merck KGaA
• BD Biosciences
• STEMCELL Technologies
• Sigma-Aldrich (MilliporeSigma)
• Lonza Group
• Corning Incorporated
• Promega Corporation
• Cell Signaling Technology
• Bio-Rad Laboratories
• PerkinElmer
• Takara Bio
• Roche
• Gibco (part of Thermo Fisher Scientific)
• F. Hoffmann-La Roche AG